Adjuvant chemo-radiotherapy in the “sandwich” method for high risk endometrial cancer—a review of literature
Open Access
- 24 June 2015
- journal article
- review article
- Published by Springer Nature in BMC Women's Health
- Vol. 15 (1) , 50
Abstract
Endometrial cancer is a common female malignancy. Patients with high-risk endometrial cancer have relatively high incidence of metastasis and recurrence. Despite complete resection, patients with stage III or IV are at high risk of local or distant recurrence. Systemic adjuvant treatment includes chemotherapy and radiotherapy. But the optimal scheduling is not known. Recently proposed sequential chemo-radiotherapy as sandwich therapy for high risk endometrial cancer have yielded encouraging results. This article is to review the adjuvant chemo-radiotherapy in the “sandwich” method for high risk endometrial cancer to help clinicians identify the most effective adjuvant treatment for patients with high risks of it. We used MEDLINE, EMBASE, Cochrane Library and CBM databases to search the literature. A systematic review was made. And most data showed “sandwich” therapy is feasible, efficacious, well-tolerated and resulted in excellent long-term progression free and overall survival in the setting of advanced endometrial cancer. Randomized trials are necessary to compare chemo-radio therapy given in the “sandwich” fashion to other means of sequencing these treatment modalities. It is also necessary to define which population is best suited for “sandwich” adjuvant therapy.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of “sandwich chemo-radiotherapy” and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: a single center experienceArchives of Gynecology and Obstetrics, 2013
- Phase II trial of adjuvant pelvic radiation “sandwiched” between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcomaGynecologic Oncology, 2012
- A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a “Sandwich” method for stage III, IV, and recurrent endometrial cancerGynecologic Oncology, 2011
- A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerGynecologic Oncology, 2009
- Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancerGynecologic Oncology, 2009
- Pilot phase II trial of radiation “sandwiched” between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC)Gynecologic Oncology, 2008
- Analysis of FIGO Stage IIIc Endometrial Cancer PatientsGynecologic Oncology, 2001
- FIGO Stage IIIC Endometrial Carcinoma with Metastases Confined to Pelvic Lymph Nodes: Analysis of Treatment Outcomes, Prognostic Variables, and Failure Patterns Following Adjuvant Radiation TherapyGynecologic Oncology, 1999
- Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrenceCancer, 1993
- Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implicationsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989